Kalvista Pharmaceuticals Inc Capital Reinvestment Ratio
Kalvista Pharmaceuticals Inc capital reinvestment ratio. Kalvista Pharmaceuticals Inc (KALV) has a Capital Reinvestment Ratio of 0.01x as of January 2018, meaning it reinvests 0% of its operating cash flow ($28.22 Million) in capital expenditures ($182.00K). Check how aggressively does Kalvista Pharmaceuticals Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Kalvista Pharmaceuticals Inc (2018–2018)
Capital reinvestment ratio of Kalvista Pharmaceuticals Inc from 2018 to 2018. This chart tracks Kalvista Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore KALV year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Kalvista Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2018–2018)
Kalvista Pharmaceuticals Inc capital reinvestment ratio by year from 2018 to 2018. For the full cash flow conversion analysis, see Kalvista Pharmaceuticals Inc operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.14x | $10.56 Million | $1.43 Million | — |